Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4275 AUD | +1.79% | +10.39% | +23.19% |
Apr. 30 | Canaccord Starts Immutep at Buy, Price Target is AU$1.00 | MT |
Apr. 24 | Immutep Shows Positive Data in Trial to Treat Squamous Cell Cancers in Head, Neck | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.19% | 332M | |
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |
- Stock Market
- Equities
- IMM Stock
- News Immutep Limited
- Baird Initiates Immutep With Outperform Rating, $7 Price Target